iShares Neuroscience and Healthcare ETF (IBRN)

Assets	$3.41M
Expense Ratio	0.47%
PE Ratio	15.83
Shares Out	150,000
Dividend (ttm)	$0.10
Dividend Yield	0.43%
Ex-Dividend Date	Dec 17, 2024
Payout Frequency	Annual
Payout Ratio	6.89%

Volume	191
Open	23.31
Previous Close	23.33
Day's Range	23.26 - 23.31
52-Week Low	17.86
52-Week High	28.74
Beta	0.70
Holdings	63
Inception Date	Aug 24, 2022

About IBRN

Fund Home Page

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Region: Global
• Stock Exchange: NYSEARCA
• Ticker Symbol: IBRN
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Neuro Biopharma and MedTech Index

Top 10 Holdings

41.85% of assets

Name	Symbol	Weight
Scholar Rock Holding Corporation	SRRK	4.77%
SK Biopharmaceuticals Co., Ltd.	326030	4.54%
Neurocrine Biosciences, Inc.	NBIX	4.37%
ACADIA Pharmaceuticals Inc.	ACAD	4.34%
Xenon Pharmaceuticals Inc.	XENE	4.04%
Biogen Inc.	BIIB	4.04%
Denali Therapeutics Inc.	DNLI	4.03%
argenx SE	ARGX	4.03%
Supernus Pharmaceuticals, Inc.	SUPN	4.01%
PTC Therapeutics, Inc.	PTCT	3.71%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 17, 2024	$0.10114	Dec 20, 2024
Dec 20, 2023	$0.0063	Dec 27, 2023
Jun 7, 2023	$0.00824	Jun 13, 2023

Performance

IBRN had a total return of -10.02% in the past year, including dividends. Since the fund's inception, the average annual return has been -2.68%.